SIGI
AZN icon

Susquehanna International Group (Ireland)’s AstraZeneca AZN Stock Holding History

Susquehanna International Group (Ireland)’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-13,682
Closed -$1.85M – 82
2024
Q1 		$1.85M Buy
13,682
+9,071
+197% +$1.2M 0.44% 29
2023
Q4 		$621K Buy
4,611
+1,210
+36% +$157K 0.14% 41
2023
Q3 		$461K Buy
+3,401
New +$465K 0.11% 43
2021
Q1 		– Sell
-5,286
Closed -$528K – 112
2020
Q4 		$528K Buy
+5,286
New +$560K 0.31% 31

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Susquehanna International Group (Ireland)'s AZN Position: Q2 2024 in Review

Susquehanna International Group (Ireland) sold out of AstraZeneca (AZN) in Q2 2024, closing a stake of 13,682 shares — an estimated $1.85M sold.

Susquehanna International Group (Ireland) first reported a position in AZN in Q4 2020 and held it in 4 quarters. The position peaked at $1.85M in Q1 2024. 1,212 funds tracked by Wall St. Rank hold AZN as of Q2 2024.

  • Susquehanna International Group (Ireland) reported no remaining AstraZeneca position as of Q2 2024 after selling out during the quarter.
  • Susquehanna International Group (Ireland) sold 13,682 AstraZeneca shares in Q2 2024, an estimated $1.85M.
  • Susquehanna International Group (Ireland) first reported a position in AstraZeneca in Q4 2020 and held it in 4 quarters.
  • Susquehanna International Group (Ireland)'s AstraZeneca position peaked at $1.85M in Q1 2024.
  • 1,212 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2024.

Based on Susquehanna International Group (Ireland)'s 13F filing for Q2 2024, filed 15 Aug 2024.